Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 24Colorectal Neoplasms 19Rectal Neoplasms 11Stomach Neoplasms 8Colonic Neoplasms 8Carcinoma, Non-Small-Cell Lung 7Carcinoma, Hepatocellular 7Neoplasm Metastasis 6Squamous Cell Carcinoma of Head and Neck 5Neoplasms 5Liver Neoplasms 5Uterine Cervical Neoplasms 4Urinary Bladder Neoplasms 4Osteosarcoma 4Esophageal Neoplasms 4Cholangiocarcinoma 4Peritoneal Neoplasms 3Ovarian Neoplasms 3Neuroblastoma 3Multiple Myeloma 3Lung Neoplasms 3Locally Advanced Rectal Cancer 3Kidney Neoplasms 3Inflammatory Breast Neoplasms 3Turcot syndrome 2Sarcoma 2Pancreatic Neoplasms 2Nasopharyngeal Carcinoma 2Head and Neck Neoplasms 2Glioblastoma 2

Interventions

Doxorubicin 3spartalizumab 1nilotinib 1lentiviral minigene vaccine of COVID-19 coronavirus 1envafolimab 1Trabectedin 1TQ-B3525 1Radiotherapy 1Proton Therapy 1Nivolumab 1Neoadjuvant Therapy 1Ipilimumab 1Immune Checkpoint Inhibitors 1Ifosfamide 1Heavy Ion Radiotherapy 1Gelclair 1Chemotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Chondrosarcoma × Neoadjuvant Therapy × Clear all
NCT00334854 2013-08-12

Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma

National Cancer Institute (NCI)

Phase 3 Unknown
250 enrolled
Sarcoma

Hemangiopericytoma, Malignant, Chondrosarcoma, Fibrosarcoma, Hemangiosarcoma, Liposarcoma, Sarcoma, Dermatofibrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡